Overview of Dr. Nusrat
Dr. Maliha Nusrat is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Sloan Kettering Bergen. She received her medical degree from Aga Khan Medical College and has been in practice 11 years. She is one of 497 doctors at Memorial Sloan Kettering Cancer Center and one of 15 doctors at Memorial Sloan Kettering Bergen who specialize in Oncology. She has more than 10 publications and over 200 citings.
Office
160 East 53rd Street
New York, NY 10022
Education & Training
- MD Anderson UTHealth Graduate School of Biomedical SciencesMS, Cancer Biology/ Biomedical Sciences, 2020
- University of Texas M D Anderson Cancer CenterFellowship, Investigational Cancer Therapeutics Fellowship In Early Drug Development, 2018 - 2019
- University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2015 - 2018
- University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2012 - 2015
- Aga Khan Medical CollegeClass of 2009
Certifications & Licensure
- NY State Medical License 2019 - 2026
- NJ State Medical License 2019 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- American Board of Medical QualityCertified in Medical Quality
Clinical Trials
- Testing the Addition of an Anti-cancer Drug, Copanlisib, to the Usual Maintenance Treatment (Trastuzumab and Pertuzumab) After Initial Chemotherapy in a Phase Ib/II Trial for Advanced HER2 Positive Breast Cancer Start of enrollment: 2021 May 20
- Testing the Addition of an Anti-cancer Drug, Copanlisib, to the Usual Immunotherapy (Nivolumab With or Without Ipilimumab) in Patients With Advanced Solid Cancers That Have Changes in the Following Genes: PIK3CA and PTEN Start of enrollment: 2020 Jul 17
Publications & Presentations
PubMed
- 4 citationsKRAS inhibition in metastatic colorectal cancer: An update.Maliha Nusrat, Rona Yaeger
Current Opinion in Pharmacology. 2023-02-01 - 1 citationsSimplified Graded Infusion Strategy for Mitigation of Oxaliplatin Hypersensitivity.Salvador Alonso Martinez, Neil H Segal, Andrea Cercek, Rona Yaeger, Zsofia Stadler
Clinical Colorectal Cancer. 2022-06-01 - 1 citationsRadiation therapy foranorectal cancer in patients with a history of prostate radiation therapy.Lara Hilal, Abraham J Wu, Marsha Reyngold, John J Cuaron, John Navilio
Frontiers in Oncology. 2022-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: